Fernanda I Arnaldez

4PUBLICATIONS
68CO-AUTHORS
Immunology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursClinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 09, 2026
Model-Informed First-In-Human Dose Selection for AZD2796, a High-Affinity Anti-LILRB2 Antibody.

|Feb 28, 2023
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.

Amy S Clark, Fangxin Hong, Richard S Finn

|Oct 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.

John A Ligon, R Taylor Sundby, Mary F Wedekind

|Feb 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.

Allison Magnuson, Suanna S Bruinooge, Harpreet Singh

Pageof 1

Frequent Collaborators

1 joint publications

Mark Penney

1 joint publications

Sofia Ferreira

1 joint publications

Karla Maloveste

1 joint publications

Steven Eck